U.S. Physical Therapy, Inc. (USPH)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NYSE
Market Cap: $1.49B
Last updated: Nov 17, 2026 at 11:05 AM ET
U.S. Physical Therapy, Inc. (USPH) Financials: Revenue, Profit and Cash Flow
U.S. Physical Therapy reported revenue of $780.99M for the fiscal year ended Dec 31, 2025, up 16.3% from the year before. That year, net income was $58.01M with a net margin of 7.4%, operating cash flow was $75.06M and free cash flow was $60.99M. The quarter ended Sep 30, 2026 had revenue of $222.56M and net income of $17.59M.
Revenue and Margins
The operating margin was 11.1% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $364.25M, a compound annual rate of 8.8%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $780.99M | +16.3% | 39.9% | 11.1% | 7.4% |
| Dec 2024 | $671.35M | +11.0% | 39.5% | 9.4% | 6.8% |
| Dec 2023 | $604.80M | +9.3% | 40.5% | 8.4% | 6.2% |
| Dec 2022 | $553.14M | +11.7% | 41.3% | 10.3% | 7.8% |
| Dec 2021 | $495.02M | +17.0% | 42.7% | 14.3% | 11.7% |
| Dec 2020 | $422.97M | -12.2% | 43.2% | 12.4% | 12.4% |
| Dec 2019 | $481.97M | +6.2% | 42.1% | 14.0% | 11.9% |
| Dec 2018 | $453.91M | +3.4% | 22.4% | 13.3% | 10.8% |
| Dec 2017 | $438.88M | +20.5% | 45.1% | 12.5% | 6.3% |
| Dec 2016 | $364.25M | N/A | 44.4% | 13.6% | 7.2% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 27.2% from the year before. In the quarter ended Sep 2026, net income fell 0.3% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $780.99M | $671.35M | $604.80M | $553.14M | $495.02M | $422.97M | $481.97M | $453.91M | $438.88M | $364.25M |
| Cost of revenue | $469.54M | $406.31M | $359.56M | $324.74M | $283.77M | $240.25M | $279.09M | $263.83M | $240.74M | $202.53M |
| Gross profit | $311.45M | $265.04M | $245.24M | $228.41M | $211.25M | $182.72M | $202.88M | $101.66M | $198.14M | $161.72M |
| Operating income | $86.68M | $62.99M | $50.51M | $56.80M | $70.65M | $52.41M | $67.42M | $60.31M | $54.73M | $49.53M |
| Net income | $58.01M | $45.60M | $37.22M | $43.41M | $57.92M | $52.49M | $57.26M | $48.84M | $27.72M | $26.27M |
| EBITDA | $108.50M | $82.37M | $70.06M | $75.22M | $85.67M | $76.45M | $77.52M | $68.03M | $64.44M | $58.31M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $222.56M | $214.06M | $198.29M | $202.73M | $197.13M | $197.34M | $183.79M | $180.45M | $168.03M | $167.19M | $155.68M | $154.80M |
| Gross profit | $90.23M | $86.53M | $76.79M | $80.76M | $78.44M | $81.56M | $70.69M | $69.11M | $66.48M | $69.14M | $60.32M | $62.60M |
| Operating income | $25.10M | $21.95M | $12.48M | $16.77M | $25.33M | $24.94M | $19.64M | $19.65M | $12.85M | $15.57M | $14.93M | -$2.43M |
| Net income | $17.59M | $14.90M | $8.16M | $9.18M | $17.64M | $17.72M | $13.47M | $12.49M | $9.78M | $11.71M | $11.62M | -$1.29M |
Balance Sheet
As of Dec 2025, total debt of $162.46M exceeded cash and equivalents by $126.89M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.20B | $1.17B | $997.24M | $858.15M | $749.43M | $594.36M | $560.85M | $443.17M | $418.98M | $351.23M |
| Current assets | $139.99M | $137.58M | $233.38M | $111.27M | $95.17M | $87.64M | $85.39M | $79.21M | $77.08M | $65.96M |
| Cash and equivalents | $35.57M | $41.36M | $152.82M | $31.59M | $28.57M | $32.92M | $23.55M | $23.37M | $21.93M | $20.05M |
| Total liabilities | $433.81M | $408.42M | $345.00M | $373.59M | $296.98M | $184.39M | $181.39M | $92.35M | $110.34M | $162.54M |
| Short-term debt | $9.87M | $11.00M | $7.69M | $7.86M | $830.00K | $4.90M | $728.00K | $1.43M | $4.04M | $1.23M |
| Long-term debt | $152.59M | $142.53M | $138.99M | $175.83M | $117.59M | $16.60M | $50.36M | $38.40M | $56.73M | $50.60M |
| Shareholder equity | $476.43M | $488.93M | $476.19M | $315.79M | $295.61M | $276.16M | $240.26M | $215.94M | $204.87M | $187.55M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.30B | $1.25B | $1.24B | $1.20B | $1.20B | $1.18B | $1.18B | $1.17B | $1.03B | $1.02B | $1.02B | $997.24M |
| Total liabilities | $508.36M | $482.22M | $459.19M | $433.81M | $413.83M | $414.01M | $420.68M | $408.42M | $358.47M | $353.17M | $345.29M | $345.00M |
| Cash and equivalents | $38.23M | $24.89M | $28.44M | $35.57M | $31.10M | $34.09M | $39.18M | $41.36M | $116.96M | $112.91M | $132.29M | $152.82M |
| Shareholder equity | $429.30M | $448.66M | $468.98M | $476.43M | $503.57M | $500.75M | $497.26M | $488.93M | $482.76M | $484.57M | $479.77M | $476.19M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 81.3% of operating cash flow. Dividends and share repurchases together came to 85.6% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $75.06M | $74.94M | $81.98M | $58.54M | $76.41M | $100.00M | $62.45M | $73.00M | $56.53M | $51.05M |
| Capital expenditures | $14.07M | $9.19M | $9.29M | $8.25M | $8.20M | $7.64M | $10.19M | $7.19M | $7.09M | $8.26M |
| Free cash flow | $60.99M | $65.75M | $72.68M | $50.29M | $68.20M | $92.36M | $52.26M | $65.81M | $49.43M | $42.79M |
| Dividends paid | $46.63M | $41.25M | $40.23M | $36.67M | $35.70M | $22.44M | $30.79M | $27.31M | $15.64M | $14.23M |
| Share repurchases | $5.57M | $0 | $0 | N/A | N/A | N/A | N/A | $265.00K | $2.36M | $1.26M |
| Investing cash flow | -$36.71M | -$149.45M | -$45.02M | -$81.27M | -$124.14M | -$51.20M | -$37.99M | -$23.91M | -$43.58M | -$32.49M |
| Financing cash flow | -$44.14M | -$36.95M | $84.27M | $25.76M | $43.38M | -$39.42M | -$24.27M | -$47.66M | -$11.06M | -$14.29M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $25.72M | $34.37M | $3.81M | $24.93M | $19.94M | $34.86M | -$4.67M | $19.41M | $22.12M | $28.99M | $4.42M | $26.84M |
| Capital expenditures | $5.07M | $5.36M | $5.37M | $3.93M | $4.32M | $3.25M | $2.58M | $2.49M | $2.52M | $2.34M | $1.84M | $2.22M |
| Free cash flow | $20.65M | $29.01M | -$1.56M | $21.01M | $15.63M | $31.61M | -$7.25M | $16.92M | $19.60M | $26.66M | $2.58M | $24.61M |
Frequently Asked Questions About USPH
What is U.S. Physical Therapy's annual revenue?
U.S. Physical Therapy reported revenue of $780.99M for the fiscal year ended Dec 31, 2025.
How fast is U.S. Physical Therapy's revenue growing?
Revenue was up 16.3% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 12.2%.
Is U.S. Physical Therapy profitable?
Yes. U.S. Physical Therapy reported net income of $58.01M for the fiscal year ended Dec 31, 2025, with a net margin of 7.4%.
How much free cash flow does USPH generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $75.06M minus capital expenditures of $14.07M produced free cash flow of $60.99M.
How much debt does U.S. Physical Therapy have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $152.59M, short-term debt of $9.87M and cash and equivalents of $35.57M.
USPH pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors